Cori Vanchieri. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Androgen Receptor AntagonistsAndrogensAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useBiomarkers, Tumor/bloodBiomarkers, Tumor/metabolismDrug Resistance, NeoplasmGefitinibGene Expression Regulation, NeoplasticGenes, Tumor Suppressor/drug effectsHumansMalePTEN PhosphohydrolasePhosphoric Monoester Hydrolases/geneticsPredictive Value of TestsProstate-Specific Antigen/bloodProstatic Neoplasms/drug therapyProstatic Neoplasms/immunologyProstatic Neoplasms/metabolismProstatic Neoplasms/pathologyProtein Kinase Inhibitors/pharmacologyProtein Kinases/drug effectsQuinazolines/pharmacologyReceptors, Androgen/metabolismSirolimus/analogs & derivativesSirolimus/pharmacologyTOR Serine-Threonine KinasesTumor Suppressor Proteins/geneticsUp-Regulation
Substances： See more » Androgen Receptor AntagonistsAndrogensAntineoplastic AgentsBiomarkers, TumorProtein Kinase InhibitorsQuinazolinesReceptors, AndrogenTumor Suppressor ProteinstemsirolimusProtein KinasesMTOR protein, humanTOR Serine-Threonine KinasesPhosphoric Monoester HydrolasesPTEN PhosphohydrolasePTEN protein, humanProstate-Specific AntigenGefitinibSirolimus
Year: 2005 PMID： 15687357 DOI： 10.1093/jnci/97.3.168
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506